Citius Oncology, Inc. (CTOR) - Latest Market Data

Price & Market Data

Price: $0.84

Daily Change: +$0.0109 / 1.30%

Daily Range: $0.792 - $0.84

Market Cap: $78,094,912

Daily Volume: 46,985

Performance Metrics

1 Week: -14.98%

1 Month: -8.88%

3 Months: -32.79%

6 Months: -28.70%

1 Year: -10.87%

YTD: -18.00%

About Citius Oncology, Inc. (CTOR)

Up-to-date insights on Citius Oncology, Inc. (CTOR). Current price: 0.84, daily change: +$0.0109 / 1.30%. Market cap: 78,094,912. Performance from 1-month to 1-year.

Details

Citius Oncology, Inc. focuses on the development and commercialization of innovative targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. is a subsidiary of Leonard-Meron Biosciences, Inc.

Selected stocks

SOLAI Limited (SLAI)

Bausch Health Companies Inc. (BHC)

Putnam Premier Income Trust (PPT)

Genenta Science S.p.A. (GNTA)

Quantum-Si Incorporated (QSI)